Wellgistics Health, Inc. (WGRX) Financial Ratios
3 years of historical data (2023–2025) · Healthcare · Medical - Distribution
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
N/A
—
5yr avg: N/A
ROE
N/A
—
5yr avg: -357.7%
30Y Low-358%·High-358%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
WGRX Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Wellgistics Health, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Market Cap | $9M | $28M | — | — |
| Enterprise Value | $33M | $53M | — | — |
| P/E Ratio → | -0.05 | — | — | — |
| P/S Ratio | 0.37 | 1.22 | — | — |
| P/B Ratio | — | — | — | — |
| P/FCF | — | — | — | — |
| P/OCF | — | — | — | — |
P/E links to full P/E history page with 30-year chart
WGRX EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| EV / Revenue | — | 2.27 | — | — |
| EV / EBITDA | — | — | — | — |
| EV / EBIT | — | — | — | — |
| EV / FCF | — | — | — | — |
WGRX Profitability
Margins and return-on-capital ratios measuring operating efficiency
Wellgistics Health, Inc. earns an operating margin of -347.9%. Operating margins have compressed from -33.9% to -347.9% over the past 3 years, signaling potential cost pressures or competitive headwinds.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Gross Margin | -41.3% | -41.3% | 9.7% | — |
| Operating Margin | -347.9% | -347.9% | -33.9% | — |
| Net Profit Margin | -433.9% | -433.9% | -37.8% | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| ROE | — | — | -357.7% | — |
| ROA | -230.7% | -230.7% | -23.8% | -855.8% |
| ROIC | -282.6% | -282.6% | -32.2% | — |
| ROCE | -813.4% | -813.4% | -73.4% | — |
WGRX Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $25M ($25M total debt minus $42571 cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Debt / Equity | — | — | 3.73 | — |
| Debt / EBITDA | — | — | — | — |
| Net Debt / Equity | — | — | 3.58 | — |
| Net Debt / EBITDA | — | — | — | — |
| Debt / FCF | — | — | — | — |
| Interest Coverage | -17.73 | -17.73 | -7.25 | -191.01 |
WGRX Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.09x is below 1.0, meaning current liabilities exceed current assets.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Current Ratio | 0.09 | 0.09 | 0.40 | 0.12 |
| Quick Ratio | 0.04 | 0.04 | 0.15 | 0.12 |
| Cash Ratio | 0.00 | 0.00 | 0.03 | 0.00 |
| Asset Turnover | — | 0.77 | 0.32 | — |
| Inventory Turnover | 20.11 | 20.11 | 1.72 | — |
| Days Sales Outstanding | — | 17.79 | 75.42 | — |
WGRX Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Wellgistics Health, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Dividend Yield | — | — | — | — |
| Payout Ratio | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Earnings Yield | — | — | — | — |
| FCF Yield | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $1M | $1M | $894400 |
Peer Comparison
Compare WGRX with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 WGRXYou | $9M | -0.0 | — | — | -41.3% | -347.9% | — | -282.6% | — |
 HSIC | $9B | 24.4 | 11.9 | 16.0 | 29.1% | 5.7% | 8.3% | 7.1% | 3.4 |
 OMI | $171M | -0.2 | 1.7 | — | — | 1.0% | -2111.6% | 1.8% | 2.6 |
 HCSG | $2B | 28.3 | 23.1 | 11.8 | 13.0% | 2.6% | 11.7% | 9.0% | 0.4 |
 MCK | $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 |
 CAH | $52B | 34.4 | 18.8 | 28.2 | 3.7% | 1.0% | — | 3378.7% | 3.0 |
 PAHC | $1B | 26.8 | 12.7 | 30.9 | 30.9% | 8.5% | 17.8% | 9.8% | 4.9 |
 RDNT | $4B | -215.0 | 21.9 | 49.4 | 4.5% | 4.5% | -1.5% | 3.0% | 7.7 |
 CVS | $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 VEEV | $25B | 28.2 | 19.7 | 18.0 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 |
 HIMS | $8B | 69.5 | 55.1 | 105.3 | 73.8% | 4.5% | 25.2% | 8.6% | 7.9 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 3 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
WGRX — Frequently Asked Questions
Quick answers to the most common questions about buying WGRX stock.
What is Wellgistics Health, Inc.'s P/E ratio?
Wellgistics Health, Inc.'s current P/E ratio is -0.0x. This places it at the 50th percentile of its historical range.
Is WGRX stock overvalued?
Based on historical data, Wellgistics Health, Inc. is trading at a P/E of -0.0x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Wellgistics Health, Inc.'s profit margins?
Wellgistics Health, Inc. has -41.3% gross margin and -347.9% operating margin.